Alps Advisors Inc Karuna Therapeutics, Inc. Transaction History

Alps Advisors Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $67,713 - $151,748	547 Added 3.09%	18,271 $4.11 Million
Q2 2022 Aug 11, 2022	SELL	$93.97 - $143.33 $1.21 Million - $1.85 Million	-12,913 Reduced 42.15%	17,724 $2.24 Million
Q1 2022 May 16, 2022	SELL	$98.9 - $132.37 $360,391 - $482,356	-3,644 Reduced 10.63%	30,637 $3.88 Million
Q4 2021 Feb 09, 2022	SELL	$110.64 - $159.4 $214,420 - $308,917	-1,938 Reduced 5.35%	34,281 $4.49 Million
Q3 2021 Nov 15, 2021	SELL	$101.2 - $125.87 $250,773 - $311,905	-2,478 Reduced 6.4%	36,219 $4.43 Million
Q2 2021 Aug 11, 2021	SELL	$107.45 - $135.95 $1.49 Million - $1.89 Million	-13,891 Reduced 26.41%	38,697 $4.41 Million
Q1 2021 May 07, 2021	BUY	$95.46 - $133.08 $427,756 - $596,331	4,481 Added 9.31%	52,588 $6.32 Million
Q4 2020 Feb 03, 2021	BUY	$75.23 - $109.23 $1.07 Million - $1.55 Million	14,170 Added 41.75%	48,107 $4.89 Million
Q3 2020 Nov 04, 2020	SELL	$71.31 - $109.74 $122,011 - $187,765	-1,711 Reduced 4.8%	33,937 $2.62 Million
Q2 2020 Aug 05, 2020	SELL	$62.14 - $117.21 $723,433 - $1.36 Million	-11,642 Reduced 24.62%	35,648 $3.97 Million
Q1 2020 May 06, 2020	SELL	$60.41 - $115.92 $309,178 - $593,278	-5,118 Reduced 9.77%	47,290 $3.41 Million
Q4 2019 Feb 07, 2020	BUY	$11.44 - $123.99 $599,547 - $6.5 Million	52,408 New	52,408 $3.95 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.